TABLE 2.

Outcomes upon treatment completion, by resistance profile and treatment regimen^a

Final drug resistance profile	Probability (%) of:
	Cure		Early relapse after cure
	First-line agents	Second-line agents	First-line agents	Second-line agents
Drug susceptible	89–99	—	4	—
RIFr	40–64	89–94	16	4
FQr	89–99	—	4	—
PZAr	83–90	—	8	—
RIFr, FQr	40–64	57–74	16	12
RIFr, PZAr	32–59	76–86	16	8
FQr, PZAr	83–90	—	8	—
RIFr, FQr, PZAr	32–59	47–68	16	12

^aAdditional details are provided in Table S1 in the supplemental material. —, not applicable, as the second-line regimen is assumed to be given only to patients with resistance to at least rifampin; RIF^r, rifampin resistance; PZA^r, pyrazinamide resistance; FQ^r, fluoroquinolone resistance.